Company Information
- Type:
- Company
- Country:
- France
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 20 February 2004
- Next Communication on Progress (COP) due on:
- 31 July 2025
Engagements
Communication On Progress
Published On | Title | Level/Status |
---|---|---|
19-Jul-2024 | 2024 Communication on Progress | Submitted |
07-Oct-2022 | Communication on Progress 2022 Expanscience | Active |
08-Oct-2021 | Communication on Progress 2020 Expanscience | Active |
08-Oct-2020 | Communication on Progress | Active |
09-Jul-2019 | Laboratoires Expanscience - Communication on Progress 2019 | Active |
09-Jul-2018 | Communication sur le progrès 2017 | Active |
03-Nov-2017 | Reporting Cycle Adjustment | Not applicable |
16-Nov-2016 | Communication on Progress | Active |
23-Dec-2014 | Communication on Progress 2014 | Active |
22-Oct-2013 | 2013 Communication on Progress | Active |
25-Jul-2013 | Grace Letter | Not applicable |
01-Aug-2012 | Communication on Progress 2012 | Active |
21-Jul-2011 | 2011 Communication on Progress | Learner |
29-Apr-2010 | 2010 Communication on Progress | Not applicable |
18-May-2009 | COP 2008 | Not applicable |
12-Feb-2008 | Expanscience COP 2007 | Not applicable |
19-Feb-2007 | Global Compact n° 8 : environnement et déchets d’emballages ménagers | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.